India has scaled up surveillance, genome sequencing after recent surge in COVID-19: National Institute of Virology
Cases of COVID-19 have never fallen to zero in India since the coronavirus disease was first detected, Naveen Kumar, Director, National Institute of Virology (NIV), Pune, said on Wednesday (June 18, 2025), adding, 'We have now scaled-up surveillance and genome sequencing following the recent surge in cases.'
The NIV was continuously monitoring the evolution of the SARS-CoV-2 coronavirus by whole genome sequencing of RT-PCR (reverse transcriptase polymerase chain reaction) positive samples referred from 73 virus research and diagnostic laboratories across the country, Dr. Kumar said.
The recent upsurge in COVID-19 cases had been noticed since the second week of April 2025, Dr. Kumar said, adding that genomic analysis had revealed the surge was due to the JN.1.16 sub-lineage of the Omicron variant, and that since May 2025, it had been replaced by the XFG (LF.7 and LP.81.2) recombinant variant. Whole genome sequences have been submitted to the Indian Biological Data Centre and GISAID (Global Initiative on Sharing All Influenza Data).
The virus isolation of the newer variants would be helpful in assessing vaccine effectiveness, and in supporting India's indigenous efforts for vaccine development, Dr. Kumar said.
'Currently, two monovalent Omicron-based vaccines are available (Biological E Limited's Corbivax, and Serum Institute of India's COVOVAX). The situation is being continuously monitored by the Union Health Ministry,' the head of the NIV said.
India reported its first cases of COVID-19 on January 30, 2020 in three towns of Kerala, in three Indian medical students who had returned from Wuhan, the epicentre of the pandemic.
India's active COVID-19 caseload dropped marginally to 6,483 on Wednesday from 6,836 the previous day, according to latest data from the Ministry of Health. Four deaths have been recorded in the past 24 hours.
Of the four deaths, two were reported in Maharashtra, while Kerala and Delhi reported one each, respectively. All four individuals were elderly, and had existing respiratory ailments and other chronic conditions.
India is currently witnessing a rise in infections driven by emerging subvariants, including LF.7, XFG, JN.1, and the newly detected NB.1.8.1.
Delhi recorded the highest number of fresh COVID-19 cases, with 65 new infections taking its total to 620. Kerala continues to report the highest number of active COVID-19 cases at 1,384, followed by Gujarat with 1,105. Karnataka and Maharashtra reported 653 and 489 active cases, respectively.
COVID-19 is the symptomatic disease caused by the SARS-CoV-2 coronavirus. Vaccination remains an important public health countermeasure against COVID-19, the World Health Organization (WHO) has said. SARS-CoV-2 continues to undergo sustained evolution since its emergence in humans, with important genetic and antigenic changes in the spike protein, the global health body said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
8 minutes ago
- Time of India
What to know about the COVID variant that may cause 'razor blade' sore throats
The COVID-19 variant that may be driving a recent rise in cases in some parts of the world has earned a new nickname: " razor blade throat " COVID. That's because the variant - NB.1.8.1. Tired of too many ads? go ad free now or "Nimbus" - may cause painful sore throats. The symptom has been identified by doctors in the United Kingdom, India and elsewhere, according to media outlets in those countries. Other COVID-19 symptoms of any variant include fever, chills, cough, shortness of breath or loss of taste or smell. Experts say there isn't major cause for concern with the Nimbus variant, but here 's what else you need to know about it. Here's where the variant causing 'razor blade throat' spreading The rise in cases late last month is primarily in eastern Mediterranean, Southeast Asia and western Pacific regions, the World Health Organization said May 28. The new variant had reached nearly 11% of sequenced samples reported globally in mid-May. Airport screening in the United States detected the new variant in travelers arriving from those regions to destinations in California, Washington state, Virginia and New York. You aren't likely to get sicker from this variant than others Not so far, anyway. The WHO said some western Pacific countries have reported increases in COVID cases and hospitalizations, but there's nothing so far to suggest that the disease associated with the new variant is more severe compared to other variants. COVID-19 vaccines are effective against the Nimbus variant Yes. The WHO has designated Nimbus as a "variant under monitoring" and considers the public health risk low at the global level. Current vaccines are expected to remain effective. Health Secretary Robert F Kennedy Jr announced last month that COVID-19 shots are no longer recommended for healthy children and pregnant women - a move immediately questioned by public health experts.
India Gazette
43 minutes ago
- India Gazette
NAKSHATRA to boost viral genomic surveillance and preparedness for future pandemics: ICMR NIV Director
By Shalini Bhardwaj Pune (Maharashtra) [India], June 18 (ANI): The NAKSHATRA state-of-the-art initiative aims to revolutionise how genomic and bioinformatics data are processed, addressing limitations faced during the COVID-19 pandemic. Speaking to ANI, ICMR-NIV Pune Director Dr Naveen Kumar, explaining about NAKSHATRA, said, 'A high-performance computing system has been launched. This is the first kind of facility for the sequence analysis or genomic surveillance of pathogens under the ICMR.' He further said, 'So nowadays, many new COVID variants, viruses, or pathogens are being reported. Our resources were insufficient because analysing the millions of sequences in the public domain takes a lot of time. We were doing extensive sequence analysis using multiple strains, which used to take we can do the same work in 24-48 hours. It has increased the capability of our country for genomic surveillance, which will help us in pandemic preparedness.' Developed under the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission (PMABHIM), the HPC facility forms the cornerstone of a new project titled 'High Performance Computing Next Generation Sequencing (NGS) Hub'. The initiative aims to revolutionize how genomic and bioinformatics data are processed, addressing limitations faced during the COVID-19 pandemic due to conventional computing infrastructure. The commissioning of the NAKSHATRA HPC facility is not just a technological upgrade--it is a national investment in speed, precision, and preparedness. By enabling faster analysis of complex genomic data, the facility positions India to detect new disease threats sooner, respond to outbreaks more efficiently, and accelerate AI-driven vaccine and drug development. (ANI)
Economic Times
an hour ago
- Economic Times
Razor blade throat Covid variant spreading very fast in U.S - Americans need to keep these things in mind
A new COVID variant called Nimbus is spreading in the US. This variant, officially known as NB.1.8.1, causes severe sore throats. Health experts are monitoring it closely due to summer travel. Nimbus appears to spread more easily. Vaccination is still important. The elderly and immunocompromised should take precautions. Tired of too many ads? Remove Ads What makes this new variant different? Tired of too many ads? Remove Ads Should you worry about Nimbus this summer? Why is 'razor blade throat' trending? Is a sore throat a direct symptom of COVID? Tired of too many ads? Remove Ads What should Americans do? FAQs A new variant of COVID is spreading in the US. The NB.1.8.1 COVID variant , which is also called Nimbus, is spreading quickly and making a lot of people have a very sore throat that feels like they're almost swallowing experts are keeping a close eye on it because summer travel makes it more likely to California, the new " razor blade throat " COVID subvariant rapidly gains traction. In a recent report, the World Health Organization labeled the variant, officially known as NB.1.8.1, a 'variant under monitoring' on May 23. It's not a serious threat at the moment, but it's spreading quickly enough to cause concern, as per a report by Sf the end of April, it accounted for 10.7% of COVID-19 samples worldwide, up from 2.5% a month to the Centers for Disease Control and Prevention (CDC), the variant, which is colloquially known as "Nimbus," accounted for an estimated 37% of cases in the United States over the two weeks ending June 7, as per a report by Fox not more virulent, Nimbus seems to be easier to spread. The virus's spike protein, which aids in cell infection, is one of the many genetic alterations in the variant, which was initially discovered in January. Some of those modifications may facilitate its spread or help the body evade the immune response, particularly in people who have already been vaccinated or infected, as per areport by SF to state officials, the variant is currently expanding more quickly than other strains and is being closely monitored using wastewater surveillance and genomic positive rates have gradually increased from 1.1% in March to 2.8% by June, despite wastewater levels seemingly stabilizing in recent weeks. The agency stated that hospitalization rates are still low and stable in spite of of the COVID subvariants have a characteristic feature, including the "razor-sharp" sore throat that Nimbus has been known to have been complaining of excruciatingly painful sore throats; some have likened the feeling to swallowing glass or razor Carolina emergency room physician Kenneth Perry, M.D., concurred that the main symptoms of every COVID strain have various sore throats have always been experienced by people with COVID," he stated, "and they are more commonly reported with Omicron. In fact, 70% of people have reported having a sore throat with COVID."A severe sore throat is not a new symptom, nor does it always suggest that COVID is the cause. Acid reflux, bacterial infections, and allergies are some of the causes of pharyngitis, the medical term for a sore cause of throat pain will determine how it is treated, so it's critical to get a medical diagnosis from a medicines and treatments for pharyngitis include honey, anti-inflammatory drugs, antibiotics, and over-the-counter antacids. While an over-the-counter antacid may be sufficient to treat acid reflux, antibiotics may be necessary for bacterial infections."Patients may have difficulty keeping up with hydration or even trouble taking medicine to help their symptoms due to the pain in their throat, which can cause them to be dehydrated.'According to the Cleveland Clinic, gargling a solution made with ½ teaspoon salt per cup of water can reduce throat irritation and the throat, gargling, sucking on lozenges, and drinking plenty of water can all help to relieve the United States, the new NB.1.8.1 variant has started to spread, and the current vaccine should protect against it. Those who are elderly or immunocompromised should update their vaccinations and wear masks as a severe sore throat, a symptom of the new NB.1.8.1 variant. Some say it's like swallowing shards of necessarily. It spreads faster, but experts believe it is not as severe as previous strains. It is still important to keep up with vaccinations.
